Azithromycin (ophthalmic) dosage and administration: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Azithromycin}} {{CMG}} ==Dosage And Administration== The recommended dosage regimen for the treatment of bacterial conjunctivitis is: Instill 1 drop in the affec..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Azithromycin}} | {{Azithromycin (ophthalmic)}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==Dosage And Administration== | ==Dosage And Administration== | ||
The recommended dosage regimen for the treatment of bacterial conjunctivitis is: | The recommended dosage regimen for the treatment of bacterial conjunctivitis is: | ||
Instill 1 drop in the affected eye(s) twice daily, eight to twelve hours apart for the first two days and then instill 1 drop in the affected eye(s) once daily for the next five days. | Instill 1 drop in the affected eye(s) twice daily, eight to twelve hours apart for the first two days and then instill 1 drop in the affected eye(s) once daily for the next five days. | ||
====Dosage Forms and Strengths==== | |||
2.5 mL of a 1% sterile topical ophthalmic solution.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = |title = AZASITE (AZITHROMYCIN) SOLUTION [INSPIRE PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5dc0f75a-1e14-469f-af4f-c668a32f2328 |publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 21:52, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Dosage And Administration
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
Instill 1 drop in the affected eye(s) twice daily, eight to twelve hours apart for the first two days and then instill 1 drop in the affected eye(s) once daily for the next five days.
Dosage Forms and Strengths
2.5 mL of a 1% sterile topical ophthalmic solution.[1]
References
Adapted from the FDA Package Insert.